China's experimental Covid-19 vaccine appears safe, researchers say

China's experimental Covid-19 vaccine appears safe, researchers say

Reuters photo
Reuters photo

SINGAPORE: A Chinese experimental coronavirus vaccine being developed by the Institute of Medical Biology under the Chinese Academy of Medical Sciences was shown to be safe in an early stage clinical trial, researchers said.

In a Phase 1 trial of 191 healthy participants aged between 18 and 59, vaccination with the group's experimental shot showed no severe adverse reactions, its researchers reported on Tuesday in a paper posted on medRxiv  preprint server ahead of peer review.

The most common adverse reactions reported by the trial participants were mild pain, slight fatigue and redness, itching and swelling at the injection site. The candidate also induced immune response.

"All the data obtained in this trial support the safety and immunogenicity of this inactivated vaccine and are encouraging with regard to further studies of its efficacy in the future," the paper said.

China has inoculated hundreds of thousands of essential workers and other groups considered at high risk with other vaccines, even as clinical trials had not been fully completed, raising safety concerns among experts.

China has at least four experimental vaccines in the final stage of clinical trials.

Do you like the content of this article?
COMMENT (19)

Beautiful freedom

The former Myanmar beauty queen who slammed the country's junta and was detained at Suvarnabhumi last week is free to fly to Canada, where she has been granted refugee status.

26 Sep 2022

Royal inspiration for a sustainable future

Thais who have learned His Majesty King Bhumibol Adulyadej the Great’s Sufficiency Economy Philosophy (SEP) are ready to put it into action as the whole world increasingly moves toward sustainable development, said Sumet Tantivejkul, Secretary-General of the Chaipattana Foundation.

26 Sep 2022

Ant Group's Alipay+ to boost cashless travel in South Korea

HONG KONG: Chinese financial technology giant Ant Group is ramping up cashless travel in South Korea through its Alipay+ programme, which supports a major collaboration between trusted mobile payment services providers across Asia.

26 Sep 2022